Sippican Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.83M | Hold |
22,030
| – | – | 1.73% | 16 |
|
|
2026
Q1 | $2.65M | Sell |
22,030
-446
| -2% | -$51.5K | 1.81% | 16 |
|
|
2025
Q4 | $2.37M | Sell |
22,476
-650
| -3% | -$61K | 1.52% | 21 |
|
|
2025
Q3 | $1.94M | Buy |
23,126
+943
| +4% | +$77.7K | 1.28% | 26 |
|
|
2025
Q2 | $1.76M | Sell |
22,183
-85
| -0.4% | -$6.76K | 1.28% | 29 |
|
|
2025
Q1 | $2M | Buy |
22,268
+850
| +4% | +$79.4K | 1.51% | 19 |
|
|
2024
Q4 | $2.13M | Buy |
21,418
+750
| +4% | +$77.3K | 1.55% | 19 |
|
|
2024
Q3 | $2.35M | Sell |
20,668
-10
| -0% | -$1.19K | 1.64% | 19 |
|
|
2024
Q2 | $2.56M | Sell |
20,678
-3
| -0% | -$386 | 2.03% | 11 |
|
|
2024
Q1 | $2.73M | Sell |
20,681
-2,284
| -10% | -$282K | 2.12% | 10 |
|
|
2023
Q4 | $2.5M | Buy |
22,965
+1,732
| +8% | +$180K | 1.96% | 9 |
|
|
2023
Q3 | $2.19M | Buy |
21,233
+300
| +1% | +$32.3K | 1.97% | 8 |
|
|
2023
Q2 | $2.42M | Sell |
20,933
-603
| -3% | -$68.5K | 2.23% | 5 |
|
|
2023
Q1 | $2.29M | Sell |
21,536
-1,902
| -8% | -$205K | 2.19% | 7 |
|
|
2022
Q4 | $2.6M | Sell |
23,438
-631
| -3% | -$64.5K | 2.49% | 5 |
|
|
2022
Q3 | $2.07M | Sell |
24,069
-815
| -3% | -$72.8K | 2.16% | 8 |
|
|
2022
Q2 | $2.27M | Sell |
24,884
-140
| -0.6% | -$12.4K | 2.25% | 7 |
|
|
2022
Q1 | $2.05M | Buy |
25,024
+576
| +2% | +$45.4K | 1.7% | 15 |
|
|
2021
Q4 | $1.87M | Buy |
24,448
+661
| +3% | +$52.6K | 1.59% | 18 |
|
|
2021
Q3 | $1.79M | Buy |
23,787
+1,420
| +6% | +$108K | 1.55% | 21 |
|
|
2021
Q2 | $1.74M | Buy |
22,367
+944
| +4% | +$70.2K | 1.51% | 21 |
|
|
2021
Q1 | $1.58M | Buy |
21,423
+2,231
| +12% | +$165K | 1.46% | 28 |
|
|
2020
Q4 | $1.5M | Sell |
19,192
-2,554
| -12% | -$195K | 1.63% | 18 |
|
|
2020
Q3 | $1.72M | Buy |
21,746
+1,312
| +6% | +$103K | 2.14% | 10 |
|
|
2020
Q2 | $1.51M | Sell |
20,434
-1,014
| -5% | -$76.3K | 2.03% | 10 |
|
|
2020
Q1 | $1.57M | Sell |
21,448
-1,275
| -6% | -$100K | 2.57% | 6 |
|
|
2019
Q4 | $1.97M | Buy |
22,723
+45
| +0.2% | +$3.7K | 2.19% | 8 |
|
|
2019
Q3 | $1.82M | Sell |
22,678
-1,052
| -4% | -$84.3K | 2.2% | 6 |
|
|
2019
Q2 | $1.9M | Sell |
23,730
-3,048
| -11% | -$233K | 2.24% | 8 |
|
|
2019
Q1 | $2.13M | Sell |
26,778
-3,144
| -11% | -$235K | 2.53% | 5 |
|
|
2018
Q4 | $2.18M | Buy |
29,922
+334
| +1% | +$23.6K | 2.95% | 4 |
|
|
2018
Q3 | $2.13M | Sell |
29,588
-2,289
| -7% | -$146K | 2.47% | 6 |
|
|
2018
Q2 | $1.85M | Sell |
31,877
-78
| -0.2% | -$4.4K | 1.85% | 15 |
|
|
2018
Q1 | $1.66M | Buy |
31,955
+2,449
| +8% | +$132K | 1.72% | 16 |
|
|
2017
Q4 | $1.58M | Buy |
29,506
+9,182
| +45% | +$509K | 1.55% | 20 |
|
|
2017
Q3 | $1.24M | Buy |
20,324
+3,447
| +20% | +$209K | 1.27% | 33 |
|
|
2017
Q2 | $1.03M | Buy |
16,877
+50
| +0.3% | +$3.04K | 1.12% | 33 |
|
|
2017
Q1 | $1.02M | Sell |
16,827
-8
| -0% | -$485 | 1.08% | 36 |
|
|
2016
Q4 | $946K | Sell |
16,835
-3,068
| -15% | -$180K | 0.99% | 37 |
|
|
2016
Q3 | $1.19M | Hold |
19,903
| – | – | 1.35% | 29 |
|
|
2016
Q2 | $1.09M | Sell |
19,903
-733
| -4% | -$39K | 1.3% | 31 |
|
|
2016
Q1 | $1.04M | Buy |
20,636
+416
| +2% | +$20.4K | 1.33% | 28 |
|
|
2015
Q4 | $1.02M | Buy |
20,220
+183
| +0.9% | +$9.23K | 1.29% | 29 |
|
|
2015
Q3 | $944K | Sell |
20,037
-288
| -1% | -$15.3K | 1.2% | 32 |
|
|
2015
Q2 | $1.1M | Sell |
20,325
-371
| -2% | -$20.8K | 1.11% | 32 |
|
|
2015
Q1 | $1.14M | Buy |
20,696
+288
| +1% | +$16.3K | 1.16% | 29 |
|
|
2014
Q4 | $1.11M | Sell |
20,408
-733
| -3% | -$40.8K | 1.1% | 29 |
|
|
2014
Q3 | $1.2M | Buy |
+21,141
| New | +$1.19M | 1.22% | 29 |
|
Other funds holding MRK
LMFP
ATO
QP
Sippican Capital Advisors's MRK Position: Q2 2026 in Review
Sippican Capital Advisors held its Merck (MRK) position steady in Q2 2026 at 22,030 shares worth $2.83M. The position accounts for 1.73% of the portfolio, ranked #16.
Sippican Capital Advisors first reported a position in MRK in Q3 2014 and has held it in 48 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Sippican Capital Advisors held 22,030 shares of Merck worth $2.83M as of Q2 2026.
- Sippican Capital Advisors left its Merck share count unchanged in Q2 2026.
- Merck made up 1.73% of Sippican Capital Advisors's portfolio in Q2 2026, its #16 holding.
- Sippican Capital Advisors first reported a position in Merck in Q3 2014 and has held it in 48 quarters since.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Sippican Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.